| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cranial skeletal system development | 1.89e-05 | 84 | 39 | 4 | GO:1904888 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 2.94e-05 | 94 | 39 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | skin development | 6.62e-05 | 373 | 39 | 6 | GO:0043588 | |
| GeneOntologyBiologicalProcess | embryonic cranial skeleton morphogenesis | 1.30e-04 | 52 | 39 | 3 | GO:0048701 | |
| GeneOntologyBiologicalProcess | muscle organ development | 1.56e-04 | 436 | 39 | 6 | GO:0007517 | |
| MousePheno | absent presphenoid bone | 3.37e-06 | 13 | 33 | 3 | MP:0004449 | |
| MousePheno | abnormal palatine bone morphology | 3.92e-06 | 46 | 33 | 4 | MP:0005249 | |
| MousePheno | abnormal cranial cartilage morphology | 5.49e-06 | 50 | 33 | 4 | MP:0030464 | |
| MousePheno | abnormal viscerocranium morphology | 6.47e-06 | 593 | 33 | 9 | MP:0005274 | |
| MousePheno | abnormal orbit morphology | 9.55e-06 | 18 | 33 | 3 | MP:0010030 | |
| MousePheno | delayed bone ossification | 1.11e-05 | 127 | 33 | 5 | MP:0000060 | |
| MousePheno | abnormal cranium morphology | 1.14e-05 | 813 | 33 | 10 | MP:0000438 | |
| MousePheno | abnormal craniofacial bone morphology | 1.32e-05 | 827 | 33 | 10 | MP:0002116 | |
| MousePheno | abnormal mouth morphology | 1.73e-05 | 670 | 33 | 9 | MP:0000452 | |
| MousePheno | abnormal jaw morphology | 2.43e-05 | 530 | 33 | 8 | MP:0000454 | |
| MousePheno | abnormal bone ossification | 3.09e-05 | 395 | 33 | 7 | MP:0008271 | |
| MousePheno | perinatal lethality | ROBO1 FLNB IRF6 FGFR2 COL12A1 RUNX1T1 FOXI3 SCD RYR1 GABRA1 FOXC2 | 3.36e-05 | 1130 | 33 | 11 | MP:0002081 |
| MousePheno | abnormal neurocranium morphology | 3.44e-05 | 269 | 33 | 6 | MP:0000074 | |
| MousePheno | thick epidermis | 3.59e-05 | 80 | 33 | 4 | MP:0001219 | |
| MousePheno | abnormal palatine bone horizontal plate morphology | 3.77e-05 | 28 | 33 | 3 | MP:0004537 | |
| MousePheno | decreased renal glomerulus number | 4.66e-05 | 30 | 33 | 3 | MP:0004505 | |
| MousePheno | cleft palate | 5.13e-05 | 289 | 33 | 6 | MP:0000111 | |
| MousePheno | oral cleft | 5.33e-05 | 291 | 33 | 6 | MP:0021164 | |
| MousePheno | abnormal presphenoid bone morphology | 6.23e-05 | 33 | 33 | 3 | MP:0004448 | |
| MousePheno | abnormal forelimb morphology | 6.25e-05 | 182 | 33 | 5 | MP:0000550 | |
| MousePheno | abnormal sphenoid bone morphology | 7.04e-05 | 95 | 33 | 4 | MP:0000104 | |
| MousePheno | absent incus | 8.06e-05 | 6 | 33 | 2 | MP:0004318 | |
| MousePheno | abnormal bronchiole morphology | 8.82e-05 | 37 | 33 | 3 | MP:0002267 | |
| MousePheno | abnormal palate morphology | 9.18e-05 | 321 | 33 | 6 | MP:0003755 | |
| MousePheno | abnormal ear morphology | 9.28e-05 | 470 | 33 | 7 | MP:0002102 | |
| MousePheno | small pterygoid bone | 1.13e-04 | 7 | 33 | 2 | MP:0004456 | |
| MousePheno | abnormal interventricular groove morphology | 1.13e-04 | 7 | 33 | 2 | MP:0004032 | |
| MousePheno | abnormal cartilage morphology | 1.18e-04 | 336 | 33 | 6 | MP:0000163 | |
| MousePheno | abnormal Meckel's cartilage morphology | 1.20e-04 | 41 | 33 | 3 | MP:0005587 | |
| MousePheno | decreased hair follicle number | 1.20e-04 | 41 | 33 | 3 | MP:0000379 | |
| MousePheno | increased brown adipose tissue amount | 1.39e-04 | 43 | 33 | 3 | MP:0000005 | |
| MousePheno | perinatal lethality, incomplete penetrance | 1.42e-04 | 503 | 33 | 7 | MP:0011090 | |
| MousePheno | decreased submandibular gland size | 1.50e-04 | 8 | 33 | 2 | MP:0009520 | |
| MousePheno | decreased hippocampal commissure size | 1.50e-04 | 8 | 33 | 2 | MP:0008222 | |
| MousePheno | palatal shelf fusion with tongue or mandible | 1.50e-04 | 8 | 33 | 2 | MP:0009884 | |
| MousePheno | abnormal facial morphology | 1.88e-04 | 910 | 33 | 9 | MP:0003743 | |
| MousePheno | thin ribs | 1.93e-04 | 9 | 33 | 2 | MP:0004674 | |
| MousePheno | cleft secondary palate | 2.17e-04 | 127 | 33 | 4 | MP:0009890 | |
| MousePheno | abnormal palate bone morphology | 2.31e-04 | 51 | 33 | 3 | MP:0009891 | |
| MousePheno | absent outer ear | 2.40e-04 | 10 | 33 | 2 | MP:0005579 | |
| MousePheno | abnormal epidermis stratum corneum morphology | 2.51e-04 | 132 | 33 | 4 | MP:0001240 | |
| MousePheno | abnormal hair follicle development | 2.74e-04 | 54 | 33 | 3 | MP:0003704 | |
| MousePheno | short snout | 2.82e-04 | 136 | 33 | 4 | MP:0000445 | |
| MousePheno | absent stapes | 2.93e-04 | 11 | 33 | 2 | MP:0004204 | |
| MousePheno | curly tail | 3.22e-04 | 57 | 33 | 3 | MP:0003051 | |
| MousePheno | abnormal axial skeleton morphology | CDKN1B ROBO1 FLNB IRF6 FGFR2 COL12A1 FOXI3 MMP14 RBBP7 RYR1 FOXC2 | 3.37e-04 | 1458 | 33 | 11 | MP:0002114 |
| MousePheno | small snout | 3.50e-04 | 144 | 33 | 4 | MP:0030190 | |
| MousePheno | abnormal maxilla morphology | 3.50e-04 | 144 | 33 | 4 | MP:0000455 | |
| MousePheno | abnormal pterygoid bone morphology | 3.51e-04 | 12 | 33 | 2 | MP:0004453 | |
| MousePheno | ostium secundum atrial septal defect | 3.51e-04 | 12 | 33 | 2 | MP:0010405 | |
| MousePheno | abnormal hair follicle morphology | 3.89e-04 | 148 | 33 | 4 | MP:0000377 | |
| MousePheno | skin fibrosis | 4.15e-04 | 13 | 33 | 2 | MP:0009932 | |
| MousePheno | neonatal lethality | 4.25e-04 | 799 | 33 | 8 | MP:0002058 | |
| MousePheno | abnormal parietal bone morphology | 4.53e-04 | 64 | 33 | 3 | MP:0000109 | |
| MousePheno | abnormal epidermis stratum spinosum morphology | 4.74e-04 | 65 | 33 | 3 | MP:0001236 | |
| MousePheno | abnormal ear development | 4.74e-04 | 65 | 33 | 3 | MP:0003938 | |
| MousePheno | tight skin | 4.83e-04 | 14 | 33 | 2 | MP:0001198 | |
| MousePheno | abnormal secondary palate morphology | 5.10e-04 | 159 | 33 | 4 | MP:0013550 | |
| MousePheno | abnormal hard palate morphology | 5.18e-04 | 67 | 33 | 3 | MP:0003756 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 5.41e-04 | 68 | 33 | 3 | MP:0003662 | |
| MousePheno | translucent skin | 5.57e-04 | 15 | 33 | 2 | MP:0001201 | |
| MousePheno | abnormal skeleton physiology | 5.70e-04 | 632 | 33 | 7 | MP:0001533 | |
| MousePheno | abnormal epidermis stratum granulosum morphology | 5.89e-04 | 70 | 33 | 3 | MP:0001239 | |
| MousePheno | neonatal lethality, incomplete penetrance | 6.19e-04 | 298 | 33 | 5 | MP:0011088 | |
| MousePheno | split xiphoid process | 6.35e-04 | 16 | 33 | 2 | MP:0004678 | |
| MousePheno | enlarged prostate gland | 6.35e-04 | 16 | 33 | 2 | MP:0004958 | |
| MousePheno | abnormal cartilage development | 6.85e-04 | 172 | 33 | 4 | MP:0000164 | |
| MousePheno | abnormal vestibulocochlear ganglion morphology | 7.19e-04 | 17 | 33 | 2 | MP:0003703 | |
| MousePheno | abnormal skin appearance | 7.40e-04 | 473 | 33 | 6 | MP:0009931 | |
| MousePheno | abnormal mandible morphology | 7.47e-04 | 176 | 33 | 4 | MP:0000458 | |
| MousePheno | abnormal adrenal medulla morphology | 8.08e-04 | 18 | 33 | 2 | MP:0008289 | |
| MousePheno | absent middle ear ossicles | 8.08e-04 | 18 | 33 | 2 | MP:0000040 | |
| MousePheno | abnormal adrenal gland morphology | 8.30e-04 | 181 | 33 | 4 | MP:0000639 | |
| MousePheno | abnormal tooth morphology | 8.30e-04 | 318 | 33 | 5 | MP:0002100 | |
| MousePheno | abnormal respiratory conducting tube morphology | 8.39e-04 | 79 | 33 | 3 | MP:0004391 | |
| MousePheno | abnormal dental arch morphology | 8.42e-04 | 319 | 33 | 5 | MP:0030254 | |
| MousePheno | abnormal head morphology | 8.71e-04 | 1120 | 33 | 9 | MP:0000432 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 8.94e-04 | 1124 | 33 | 9 | MP:0011112 | |
| MousePheno | abnormal craniofacial morphology | 9.00e-04 | 1372 | 33 | 10 | MP:0000428 | |
| MousePheno | craniofacial phenotype | 9.00e-04 | 1372 | 33 | 10 | MP:0005382 | |
| MousePheno | abnormal brown adipose tissue amount | 9.35e-04 | 82 | 33 | 3 | MP:0001778 | |
| MousePheno | abnormal chondrocyte morphology | 9.68e-04 | 83 | 33 | 3 | MP:0000166 | |
| MousePheno | abnormal otic vesicle development | 1.00e-03 | 20 | 33 | 2 | MP:0006030 | |
| MousePheno | domed cranium | 1.04e-03 | 85 | 33 | 3 | MP:0000440 | |
| MousePheno | abnormal pterygoid process morphology | 1.10e-03 | 21 | 33 | 2 | MP:0004452 | |
| MousePheno | abnormal temporal bone squamous part morphology | 1.10e-03 | 21 | 33 | 2 | MP:0004423 | |
| MousePheno | exophthalmos | 1.10e-03 | 21 | 33 | 2 | MP:0002750 | |
| MousePheno | perinatal lethality, complete penetrance | 1.15e-03 | 712 | 33 | 7 | MP:0011089 | |
| MousePheno | decreased cranium length | 1.21e-03 | 22 | 33 | 2 | MP:0011862 | |
| MousePheno | small ears | 1.21e-03 | 22 | 33 | 2 | MP:0000018 | |
| MousePheno | abnormal pilosebaceous unit morphology | 1.32e-03 | 205 | 33 | 4 | MP:0030572 | |
| MousePheno | decreased diameter of long bones | 1.33e-03 | 23 | 33 | 2 | MP:0008150 | |
| MousePheno | abnormal incus morphology | 1.44e-03 | 24 | 33 | 2 | MP:0005106 | |
| MousePheno | decreased skeletal muscle weight | 1.44e-03 | 24 | 33 | 2 | MP:0010239 | |
| MousePheno | abnormal submandibular gland morphology | 1.70e-03 | 26 | 33 | 2 | MP:0003793 | |
| MousePheno | kyphoscoliosis | 1.83e-03 | 27 | 33 | 2 | MP:0000069 | |
| MousePheno | abnormal hippocampal commissure morphology | 1.97e-03 | 28 | 33 | 2 | MP:0008221 | |
| MousePheno | delayed intramembranous bone ossification | 1.97e-03 | 28 | 33 | 2 | MP:0003420 | |
| MousePheno | kyphosis | 1.98e-03 | 229 | 33 | 4 | MP:0000160 | |
| MousePheno | abnormal vertebral column morphology | 2.06e-03 | 787 | 33 | 7 | MP:0004703 | |
| Domain | fn3 | 3.91e-04 | 162 | 40 | 4 | PF00041 | |
| Domain | FN3 | 6.45e-04 | 185 | 40 | 4 | SM00060 | |
| Domain | Ig_I-set | 7.12e-04 | 190 | 40 | 4 | IPR013098 | |
| Domain | I-set | 7.12e-04 | 190 | 40 | 4 | PF07679 | |
| Domain | FN3 | 8.46e-04 | 199 | 40 | 4 | PS50853 | |
| Domain | FN3_dom | 1.02e-03 | 209 | 40 | 4 | IPR003961 | |
| Domain | IGc2 | 1.56e-03 | 235 | 40 | 4 | SM00408 | |
| Domain | Ig_sub2 | 1.56e-03 | 235 | 40 | 4 | IPR003598 | |
| Domain | - | 2.68e-03 | 663 | 40 | 6 | 2.60.40.10 | |
| Domain | Ig-like_fold | 3.66e-03 | 706 | 40 | 6 | IPR013783 | |
| Domain | TF_fork_head_CS_2 | 4.36e-03 | 46 | 40 | 2 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 4.55e-03 | 47 | 40 | 2 | IPR018122 | |
| Domain | FORK_HEAD_3 | 4.94e-03 | 49 | 40 | 2 | PS50039 | |
| Domain | FH | 4.94e-03 | 49 | 40 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.94e-03 | 49 | 40 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.94e-03 | 49 | 40 | 2 | PS00658 | |
| Domain | Forkhead | 4.94e-03 | 49 | 40 | 2 | PF00250 | |
| Domain | Fork_head_dom | 4.94e-03 | 49 | 40 | 2 | IPR001766 | |
| Domain | - | 1.13e-02 | 218 | 40 | 3 | 1.10.10.10 | |
| Domain | IG | 1.23e-02 | 421 | 40 | 4 | SM00409 | |
| Domain | Ig_sub | 1.23e-02 | 421 | 40 | 4 | IPR003599 | |
| Pubmed | 9.07e-08 | 329 | 40 | 7 | 17474147 | ||
| Pubmed | USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma. | 1.29e-06 | 2 | 40 | 2 | 29533940 | |
| Pubmed | Regulation of GABA(A) receptor dynamics by interaction with purinergic P2X(2) receptors. | 1.29e-06 | 2 | 40 | 2 | 21343285 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17557804 | ||
| Pubmed | Midline crossing and Slit responsiveness of commissural axons require USP33. | 1.29e-06 | 2 | 40 | 2 | 19684588 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 34517516 | ||
| Pubmed | 1.67e-06 | 1006 | 40 | 9 | 15226823 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 30896071 | ||
| Pubmed | USP33, a new player in lung cancer, mediates Slit-Robo signaling. | 3.87e-06 | 3 | 40 | 2 | 24981056 | |
| Pubmed | FKBP3 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through Regulating Sp1/HDAC2/p27. | 7.73e-06 | 4 | 40 | 2 | 28839465 | |
| Pubmed | 1.57e-05 | 42 | 40 | 3 | 29107558 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 19706539 | ||
| Pubmed | Fibroblast growth factor signaling regulates Dach1 expression during skeletal development. | 2.70e-05 | 7 | 40 | 2 | 12203718 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 15729360 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 18297725 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 31600777 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 25344367 | ||
| Pubmed | 3.79e-05 | 331 | 40 | 5 | 20634891 | ||
| Pubmed | Fgf20 is required for sensory epithelial specification in the developing cochlea. | 7.05e-05 | 11 | 40 | 2 | 18524904 | |
| Pubmed | Somatic FGFR2 is Required for Germ Cell Maintenance in the Mouse Ovary. | 7.05e-05 | 11 | 40 | 2 | 36786658 | |
| Pubmed | Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4. | 7.05e-05 | 11 | 40 | 2 | 14512019 | |
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 15342473 | ||
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 19937600 | ||
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 32015493 | ||
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 12920132 | ||
| Pubmed | The effects of aging on gene expression in the hypothalamus and cortex of mice. | 1.05e-04 | 79 | 40 | 3 | 11172053 | |
| Pubmed | 1.09e-04 | 215 | 40 | 4 | 35973513 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 1.10e-04 | 670 | 40 | 6 | 22990118 | |
| Pubmed | 1.13e-04 | 81 | 40 | 3 | 39217171 | ||
| Pubmed | FGFR and PTEN signaling interact during lens development to regulate cell survival. | 1.16e-04 | 14 | 40 | 2 | 26764128 | |
| Pubmed | 1.34e-04 | 15 | 40 | 2 | 22235191 | ||
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 37715952 | ||
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 25196150 | ||
| Pubmed | Fibroblast growth factor receptor signaling is essential for lens fiber cell differentiation. | 1.73e-04 | 17 | 40 | 2 | 18455718 | |
| Pubmed | Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. | 1.95e-04 | 18 | 40 | 2 | 31910261 | |
| Pubmed | Cochlear progenitor number is controlled through mesenchymal FGF receptor signaling. | 1.95e-04 | 18 | 40 | 2 | 25915623 | |
| Pubmed | Midline radial glia translocation and corpus callosum formation require FGF signaling. | 1.95e-04 | 18 | 40 | 2 | 16715082 | |
| Pubmed | Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. | 1.95e-04 | 18 | 40 | 2 | 20064376 | |
| Pubmed | Genome-wide association study of liver enzymes in korean children. | 2.18e-04 | 19 | 40 | 2 | 24124411 | |
| Pubmed | 2.42e-04 | 20 | 40 | 2 | 19369394 | ||
| Pubmed | 2.42e-04 | 20 | 40 | 2 | 38113115 | ||
| Pubmed | MT1-MMP inactivates ADAM9 to regulate FGFR2 signaling and calvarial osteogenesis. | 2.67e-04 | 21 | 40 | 2 | 22632802 | |
| Pubmed | 2.94e-04 | 22 | 40 | 2 | 27146480 | ||
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 23451260 | ||
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 29981310 | ||
| Pubmed | The mouse Foxi3 transcription factor is necessary for the development of posterior placodes. | 3.50e-04 | 24 | 40 | 2 | 26550799 | |
| Pubmed | Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. | 3.80e-04 | 25 | 40 | 2 | 9560157 | |
| Pubmed | 3.80e-04 | 25 | 40 | 2 | 25664857 | ||
| Pubmed | GATA3 controls the specification of prosensory domain and neuronal survival in the mouse cochlea. | 4.45e-04 | 27 | 40 | 2 | 23666531 | |
| Pubmed | Purification of CpG islands using a methylated DNA binding column. | 4.78e-04 | 28 | 40 | 2 | 8012384 | |
| Pubmed | Fgf10 is required for specification of non-sensory regions of the cochlear epithelium. | 5.13e-04 | 29 | 40 | 2 | 25624266 | |
| Pubmed | 5.13e-04 | 29 | 40 | 2 | 25336744 | ||
| Pubmed | Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. | 5.13e-04 | 29 | 40 | 2 | 14522949 | |
| Pubmed | Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function. | 5.50e-04 | 30 | 40 | 2 | 27133129 | |
| Pubmed | Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. | 5.87e-04 | 31 | 40 | 2 | 19898483 | |
| Pubmed | Mesodermal Pten inactivation leads to alveolar capillary dysplasia- like phenotype. | 5.87e-04 | 31 | 40 | 2 | 23023706 | |
| Pubmed | 6.26e-04 | 32 | 40 | 2 | 23154389 | ||
| Pubmed | 7.07e-04 | 34 | 40 | 2 | 21172336 | ||
| Pubmed | 7.49e-04 | 35 | 40 | 2 | 15031101 | ||
| Pubmed | 8.60e-04 | 371 | 40 | 4 | 25241761 | ||
| Pubmed | FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice. | 8.83e-04 | 38 | 40 | 2 | 26134413 | |
| Pubmed | 9.30e-04 | 39 | 40 | 2 | 33580754 | ||
| Pubmed | Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b. | 9.30e-04 | 39 | 40 | 2 | 23341776 | |
| Pubmed | 9.30e-04 | 39 | 40 | 2 | 25859222 | ||
| Pubmed | 9.60e-04 | 1007 | 40 | 6 | 34597346 | ||
| Pubmed | 9.79e-04 | 40 | 40 | 2 | 26657772 | ||
| Pubmed | 1.04e-03 | 173 | 40 | 3 | 23979707 | ||
| GeneFamily | Fibronectin type III domain containing | 1.02e-04 | 160 | 28 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.05e-04 | 161 | 28 | 4 | 593 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP | 1.12e-05 | 199 | 39 | 5 | M8863 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 1.61e-05 | 33 | 39 | 3 | M1904 | |
| Coexpression | VALK_AML_WITH_T_8_21_TRANSLOCATION | 2.15e-05 | 5 | 39 | 2 | M17966 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 2.28e-05 | 37 | 39 | 3 | MM1258 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 4.66e-05 | 268 | 39 | 5 | M45696 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 189 | 40 | 5 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 189 | 40 | 5 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-07 | 191 | 40 | 5 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-07 | 191 | 40 | 5 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.24e-07 | 194 | 40 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.67e-07 | 196 | 40 | 5 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.67e-07 | 196 | 40 | 5 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.67e-07 | 196 | 40 | 5 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-07 | 197 | 40 | 5 | 8b3bf5b45e49bf1c60e4d2703b470bb890385f67 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-07 | 197 | 40 | 5 | 02e70768a917c5f097bc653e9e965a1000289d2e | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.34e-07 | 199 | 40 | 5 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.57e-07 | 200 | 40 | 5 | 1b5ac5b3ddd4df32e940531cc020998f8cd95c2c | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.61e-06 | 130 | 40 | 4 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 169 | 40 | 4 | d18b823836ca6fba79a2d2f10cb9966fa2623af2 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 169 | 40 | 4 | befb9b1618ea30fbf8983bcc493853da53b809c3 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.58e-05 | 169 | 40 | 4 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 173 | 40 | 4 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 173 | 40 | 4 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-05 | 173 | 40 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.77e-05 | 174 | 40 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.81e-05 | 175 | 40 | 4 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.98e-05 | 179 | 40 | 4 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 180 | 40 | 4 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-05 | 181 | 40 | 4 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-05 | 181 | 40 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-05 | 182 | 40 | 4 | 97bb07478f56a937b490fba121ee603db64134a1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-05 | 182 | 40 | 4 | 1c1a687f728341c209b048b6715bcddd0ac20069 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 183 | 40 | 4 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-05 | 183 | 40 | 4 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-05 | 184 | 40 | 4 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.21e-05 | 184 | 40 | 4 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.21e-05 | 184 | 40 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 185 | 40 | 4 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 185 | 40 | 4 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 2.25e-05 | 185 | 40 | 4 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 186 | 40 | 4 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.35e-05 | 187 | 40 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 188 | 40 | 4 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 188 | 40 | 4 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.40e-05 | 188 | 40 | 4 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 40 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 189 | 40 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 190 | 40 | 4 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 190 | 40 | 4 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.50e-05 | 190 | 40 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 191 | 40 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 2.55e-05 | 191 | 40 | 4 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-05 | 191 | 40 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 192 | 40 | 4 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-05 | 192 | 40 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 192 | 40 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 192 | 40 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-05 | 192 | 40 | 4 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 192 | 40 | 4 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.60e-05 | 192 | 40 | 4 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-05 | 192 | 40 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-05 | 192 | 40 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-05 | 192 | 40 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 193 | 40 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.66e-05 | 193 | 40 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.66e-05 | 193 | 40 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.66e-05 | 193 | 40 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.66e-05 | 193 | 40 | 4 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.66e-05 | 193 | 40 | 4 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.66e-05 | 193 | 40 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-05 | 194 | 40 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 194 | 40 | 4 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 194 | 40 | 4 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-05 | 194 | 40 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 194 | 40 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 195 | 40 | 4 | e10b21e4dba4483efc4c82d6e395524246ca14a8 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-05 | 195 | 40 | 4 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 195 | 40 | 4 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.77e-05 | 195 | 40 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.77e-05 | 195 | 40 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 195 | 40 | 4 | 9ab3c5b0fb12d406408122a535b717bfe184bbcf | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 2.77e-05 | 195 | 40 | 4 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 195 | 40 | 4 | 21263d138c81f6a0219f2cd93126cfafd35732b2 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-05 | 195 | 40 | 4 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 195 | 40 | 4 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 196 | 40 | 4 | a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 196 | 40 | 4 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.82e-05 | 196 | 40 | 4 | e3c89c5bd674289738d5590ebfd30c605f5156a5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-05 | 196 | 40 | 4 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-05 | 196 | 40 | 4 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-05 | 196 | 40 | 4 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 196 | 40 | 4 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 196 | 40 | 4 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 196 | 40 | 4 | c390ef0adff35111989a30dff86b7c5db1a89873 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 196 | 40 | 4 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 196 | 40 | 4 | 2f76f050083483f0880639e6c34ff349caac3503 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 196 | 40 | 4 | 476812fc1422aca8010d771eff11fa6081f15a2d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-05 | 196 | 40 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 196 | 40 | 4 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 197 | 40 | 4 | bc6c530330907a5ec823cc243c8e9c9e340cfb9c | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.88e-05 | 197 | 40 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| Disease | transitional cell carcinoma (is_marker_for) | 8.02e-05 | 63 | 39 | 3 | DOID:2671 (is_marker_for) | |
| Disease | cleft palate (is_implicated_in) | 1.11e-04 | 12 | 39 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Skin Abnormalities | 1.32e-04 | 13 | 39 | 2 | C0037268 | |
| Disease | lysophosphatidylcholine 16:1 measurement | 1.53e-04 | 14 | 39 | 2 | EFO_0010358 | |
| Disease | Cleft Palate | 1.70e-04 | 81 | 39 | 3 | C0008925 | |
| Disease | leptin measurement | 1.70e-04 | 81 | 39 | 3 | EFO_0005000 | |
| Disease | Limb Deformities, Congenital | 2.29e-04 | 17 | 39 | 2 | C0206762 | |
| Disease | lysophosphatidylethanolamine 20:4 measurement | 6.76e-04 | 29 | 39 | 2 | EFO_0010370 | |
| Disease | interleukin 4 measurement | 1.04e-03 | 36 | 39 | 2 | EFO_0008184 | |
| Disease | Craniofacial Abnormalities | 1.15e-03 | 156 | 39 | 3 | C0376634 | |
| Disease | rheumatoid arthritis, Crohn's disease | 1.16e-03 | 38 | 39 | 2 | EFO_0000384, EFO_0000685 | |
| Disease | Cleft upper lip | 1.22e-03 | 39 | 39 | 2 | C0008924 | |
| Disease | lysophosphatidylcholine 20:3 measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0010362 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPGDEIYPRDENGKW | 126 | P51857 | |
| KEKAPDVFDWGSSGP | 241 | Q9NPY3 | |
| RQPKDGKEWGEEYVT | 221 | A8MVX0 | |
| PQDEWTGYTPRGKDD | 321 | O14490 | |
| EGKYEWQEVEKGSLP | 71 | P46527 | |
| WKMDGPGYGDEEEPL | 136 | Q9NV06 | |
| DSEYPKNIKVWEGIP | 446 | P50281 | |
| DPYGDIWLTDKQPEE | 196 | Q6NSI4 | |
| AGVSEYELPEDPKWE | 461 | P21802 | |
| VPRDEDDPGKGNYWT | 206 | A8MTJ6 | |
| KIEGYPDPEVVWFKD | 1831 | Q15746 | |
| KAPEDCEDGELPYGW | 331 | Q5TCQ9 | |
| PASGYVPEEIWKKAE | 436 | Q06455 | |
| KHIWYIGGKNEPEPE | 266 | Q8IWQ3 | |
| DGSCDVKYWPKEPGE | 601 | O75369 | |
| EKEDPEPSTDGTYVW | 391 | Q9UHG3 | |
| YDEWPIKLGEVEPYK | 291 | P51160 | |
| PYVENVGGKWEKPSE | 246 | Q9H1A3 | |
| GYAWDGKSVVPEKPK | 341 | P14867 | |
| DDKKPGKGSYWTLDP | 136 | Q99958 | |
| VQWLPEVTKPEGKDY | 46 | Q16576 | |
| IETPEPGKWELSGYE | 11 | Q14397 | |
| KVWDVEEYVKPPEGG | 91 | Q9UBL9 | |
| PDIAWYKKGGDLPSD | 276 | O94856 | |
| VPGEKPGTKVDDYWE | 2966 | Q9P2D7 | |
| PGTKVDDYWEPGKGL | 2971 | Q9P2D7 | |
| TDYEDLKPDGWPSAK | 236 | Q8NBI3 | |
| TWEPAPGEVKGYKVT | 1106 | Q99715 | |
| IPKDSVGTQEWYPKD | 96 | Q30KQ8 | |
| EIEPEWAYGKKGQPD | 191 | Q00688 | |
| KGYPGVQAPEDLEWE | 346 | P05060 | |
| PPKKEEAGGEFWGEL | 4531 | P21817 | |
| KYQEGVDDPDPAKWK | 66 | O14896 | |
| KVIYGGEVWGKSPEP | 31 | Q9BWW9 | |
| EKSGKWEGLVYAPPG | 466 | Q9Y2W1 | |
| TTDNKEPIPDDGIYW | 221 | Q9BUI4 | |
| DKEGPSPKVEYVWRN | 61 | O00767 | |
| WYKGGERVETDKDDP | 101 | Q9Y6N7 | |
| YIGTEPWKPKEAVEE | 206 | Q96KB5 | |
| DPGLKKGYWAPEEDA | 396 | Q5SXM2 | |
| REWESFVKGKDGDPP | 856 | Q8TEY7 |